Roth Capital Downgrades Peregrine Pharmaceuticals (PPHM) to Neutral
Tweet Send to a FriendGet Alerts PPHM Hot Sheet
Price: $1.48 -1.33%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade PPHM Now!
Roth Capital downgraded Peregrine Pharmaceuticals (NASDAQ: PPHM) from Buy to Neutral with a price target of $0.70 (from $9.00).
For an analyst ratings summary and ratings history on Peregrine Pharmaceuticals click here. For more ratings news on Peregrine Pharmaceuticals click here.
Shares of Peregrine Pharmaceuticals closed at $5.39 yesterday, with a 52 week range of $0.39-$5.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Peregrine Pharmaceuticals click here. For more ratings news on Peregrine Pharmaceuticals click here.
Shares of Peregrine Pharmaceuticals closed at $5.39 yesterday, with a 52 week range of $0.39-$5.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bernstein Cuts BlackBerry (BBRY) to Underperform; Notes Weak BB10 Traction
- UPDATE: Raymond James Downgrades Gevo, Inc. (GEVO) to Market Perform
- Adobe (ADBE) Posts Positive Creative Cloud Subscriber Surprise in Q2 - Jefferies
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
